Targeting 40% eps growth
- Forums
- ASX - By Stock
- ACF
- Ann: FY21 Full Year Results Presentation
ACF
acrow limited
Add to My Watchlist
0.00%
!
$1.02

Ann: FY21 Full Year Results Presentation, page-2
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.02 |
Change
0.000(0.00%) |
Mkt cap ! $312.5M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 500 | $1.02 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
98.5¢ | 21 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 14917 | 0.995 |
3 | 6748 | 0.990 |
1 | 1708 | 0.985 |
3 | 11051 | 0.980 |
2 | 26544 | 0.970 |
Price($) | Vol. | No. |
---|---|---|
1.010 | 23385 | 2 |
1.015 | 25000 | 1 |
1.020 | 19000 | 2 |
1.025 | 3000 | 1 |
1.030 | 11492 | 2 |
Last trade - 09.31am 07/07/2025 (20 minute delay) ? |
Featured News
ACF (ASX) Chart |
Day chart unavailable
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online